Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Flolan

Epoprostenol Sodium

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Flolan:

 BioPortfolio Logo
A Drug That Improves Exercise Capacity by a Greater Percentage Than Tracleer Would Earn a 48 Percent Patient Share in the Pulmonary Arterial Hypertension Market 22nd July, 2008 Decision Resources
WALTHAM, Mass., July 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a therapy that
Biotech Tracker news - Sitaxsentan May Stack Up Well Against Other 1st January, 1970 Biotracker
  Sitaxsentan May Stack Up Well Against Other Pulmonary Arterial Hypertension Treatments  

This page has been viewed 24 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Flolan across BioPortfolio, or for Flolan Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.